Brief: Mereo BioPharma Group PLC Says May Offer And Sell ADSS For Offering Price Of Up To $175 Mln
15/05/2024 22:38
May 15 (Reuters) - Mereo Biopharma Group PLC MAH0y.F :
* MEREO BIOPHARMA GROUP PLC - MAY OFFER AND SELL FROM TIME
TO
TIME, ADSS FOR AGGREGATE OFFERING PRICE OF UP TO $175 MILLION IN
ONE OR MORE OFFERINGS
Source text for Eikon: ID:n0001193125-24-139456
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand